nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranylcypromine—CYP2A6—Fluorouracil—urinary bladder cancer	0.118	0.252	CbGbCtD
Tranylcypromine—CYP3A4—Thiotepa—urinary bladder cancer	0.0723	0.155	CbGbCtD
Tranylcypromine—CYP2E1—Etoposide—urinary bladder cancer	0.0647	0.139	CbGbCtD
Tranylcypromine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0449	0.0963	CbGbCtD
Tranylcypromine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0404	0.0868	CbGbCtD
Tranylcypromine—CYP1A2—Etoposide—urinary bladder cancer	0.0374	0.0804	CbGbCtD
Tranylcypromine—CYP2C9—Cisplatin—urinary bladder cancer	0.0343	0.0737	CbGbCtD
Tranylcypromine—CYP2D6—Doxorubicin—urinary bladder cancer	0.021	0.0452	CbGbCtD
Tranylcypromine—CYP3A4—Etoposide—urinary bladder cancer	0.0196	0.0421	CbGbCtD
Tranylcypromine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0134	0.0287	CbGbCtD
Tranylcypromine—CYP2C19—urine—urinary bladder cancer	0.00912	0.0884	CbGeAlD
Tranylcypromine—CYP1A2—urine—urinary bladder cancer	0.00745	0.0722	CbGeAlD
Tranylcypromine—CYP2C9—urine—urinary bladder cancer	0.00707	0.0685	CbGeAlD
Tranylcypromine—CYP2E1—urine—urinary bladder cancer	0.0067	0.0649	CbGeAlD
Tranylcypromine—CYP3A4—urine—urinary bladder cancer	0.00539	0.0522	CbGeAlD
Tranylcypromine—CYP2D6—urine—urinary bladder cancer	0.0053	0.0514	CbGeAlD
Tranylcypromine—CYP2A6—prostate gland—urinary bladder cancer	0.00509	0.0493	CbGeAlD
Tranylcypromine—CYP2A6—seminal vesicle—urinary bladder cancer	0.0043	0.0417	CbGeAlD
Tranylcypromine—MAOB—prostate gland—urinary bladder cancer	0.00375	0.0364	CbGeAlD
Tranylcypromine—MAOA—prostate gland—urinary bladder cancer	0.0032	0.0311	CbGeAlD
Tranylcypromine—MAOB—seminal vesicle—urinary bladder cancer	0.00318	0.0308	CbGeAlD
Tranylcypromine—MAOA—seminal vesicle—urinary bladder cancer	0.00271	0.0263	CbGeAlD
Tranylcypromine—MAOB—renal system—urinary bladder cancer	0.00256	0.0248	CbGeAlD
Tranylcypromine—MAOB—urethra—urinary bladder cancer	0.00251	0.0244	CbGeAlD
Tranylcypromine—CYP2A6—vagina—urinary bladder cancer	0.00251	0.0243	CbGeAlD
Tranylcypromine—CYP2E1—prostate gland—urinary bladder cancer	0.0024	0.0233	CbGeAlD
Tranylcypromine—MAOA—renal system—urinary bladder cancer	0.00218	0.0212	CbGeAlD
Tranylcypromine—MAOA—urethra—urinary bladder cancer	0.00214	0.0208	CbGeAlD
Tranylcypromine—MAOB—female reproductive system—urinary bladder cancer	0.00205	0.0199	CbGeAlD
Tranylcypromine—CYP2E1—seminal vesicle—urinary bladder cancer	0.00203	0.0197	CbGeAlD
Tranylcypromine—MAOB—vagina—urinary bladder cancer	0.00185	0.018	CbGeAlD
Tranylcypromine—CYP1A2—renal system—urinary bladder cancer	0.00182	0.0177	CbGeAlD
Tranylcypromine—MAOA—female reproductive system—urinary bladder cancer	0.00175	0.017	CbGeAlD
Tranylcypromine—CYP2E1—renal system—urinary bladder cancer	0.00164	0.0159	CbGeAlD
Tranylcypromine—CYP2C19—vagina—urinary bladder cancer	0.00162	0.0157	CbGeAlD
Tranylcypromine—CYP2E1—urethra—urinary bladder cancer	0.00161	0.0156	CbGeAlD
Tranylcypromine—MAOA—vagina—urinary bladder cancer	0.00158	0.0153	CbGeAlD
Tranylcypromine—CYP2C9—female reproductive system—urinary bladder cancer	0.00138	0.0134	CbGeAlD
Tranylcypromine—CYP3A4—renal system—urinary bladder cancer	0.00132	0.0128	CbGeAlD
Tranylcypromine—CYP2E1—female reproductive system—urinary bladder cancer	0.00131	0.0127	CbGeAlD
Tranylcypromine—CYP2D6—renal system—urinary bladder cancer	0.0013	0.0126	CbGeAlD
Tranylcypromine—MAOB—lymph node—urinary bladder cancer	0.0012	0.0116	CbGeAlD
Tranylcypromine—CYP3A4—female reproductive system—urinary bladder cancer	0.00106	0.0102	CbGeAlD
Tranylcypromine—CYP2D6—female reproductive system—urinary bladder cancer	0.00104	0.0101	CbGeAlD
Tranylcypromine—MAOA—lymph node—urinary bladder cancer	0.00102	0.00992	CbGeAlD
Tranylcypromine—Alopecia—Etoposide—urinary bladder cancer	0.000652	0.00268	CcSEcCtD
Tranylcypromine—Hypertension—Gemcitabine—urinary bladder cancer	0.000649	0.00266	CcSEcCtD
Tranylcypromine—Somnolence—Thiotepa—urinary bladder cancer	0.000648	0.00266	CcSEcCtD
Tranylcypromine—Anaemia—Cisplatin—urinary bladder cancer	0.000648	0.00266	CcSEcCtD
Tranylcypromine—Decreased appetite—Thiotepa—urinary bladder cancer	0.000634	0.0026	CcSEcCtD
Tranylcypromine—Leukopenia—Cisplatin—urinary bladder cancer	0.000627	0.00257	CcSEcCtD
Tranylcypromine—Pain—Thiotepa—urinary bladder cancer	0.000624	0.00256	CcSEcCtD
Tranylcypromine—Constipation—Thiotepa—urinary bladder cancer	0.000624	0.00256	CcSEcCtD
Tranylcypromine—Muscle spasms—Etoposide—urinary bladder cancer	0.000617	0.00253	CcSEcCtD
Tranylcypromine—Oedema—Gemcitabine—urinary bladder cancer	0.000613	0.00252	CcSEcCtD
Tranylcypromine—Confusional state—Fluorouracil—urinary bladder cancer	0.000608	0.0025	CcSEcCtD
Tranylcypromine—Oedema—Fluorouracil—urinary bladder cancer	0.000603	0.00248	CcSEcCtD
Tranylcypromine—Feeling abnormal—Thiotepa—urinary bladder cancer	0.000601	0.00247	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Gemcitabine—urinary bladder cancer	0.000601	0.00247	CcSEcCtD
Tranylcypromine—Ataxia—Methotrexate—urinary bladder cancer	0.0006	0.00246	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Thiotepa—urinary bladder cancer	0.000596	0.00245	CcSEcCtD
Tranylcypromine—Anxiety—Cisplatin—urinary bladder cancer	0.000594	0.00244	CcSEcCtD
Tranylcypromine—Anaemia—Etoposide—urinary bladder cancer	0.000593	0.00244	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Gemcitabine—urinary bladder cancer	0.000593	0.00243	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Fluorouracil—urinary bladder cancer	0.000591	0.00242	CcSEcCtD
Tranylcypromine—Tachycardia—Fluorouracil—urinary bladder cancer	0.000589	0.00242	CcSEcCtD
Tranylcypromine—Anorexia—Gemcitabine—urinary bladder cancer	0.000585	0.0024	CcSEcCtD
Tranylcypromine—Urticaria—Thiotepa—urinary bladder cancer	0.000579	0.00238	CcSEcCtD
Tranylcypromine—Abdominal pain—Thiotepa—urinary bladder cancer	0.000577	0.00237	CcSEcCtD
Tranylcypromine—Body temperature increased—Thiotepa—urinary bladder cancer	0.000577	0.00237	CcSEcCtD
Tranylcypromine—Anorexia—Fluorouracil—urinary bladder cancer	0.000575	0.00236	CcSEcCtD
Tranylcypromine—Leukopenia—Etoposide—urinary bladder cancer	0.000575	0.00236	CcSEcCtD
Tranylcypromine—Hypotension—Gemcitabine—urinary bladder cancer	0.000573	0.00235	CcSEcCtD
Tranylcypromine—Oedema—Cisplatin—urinary bladder cancer	0.000572	0.00235	CcSEcCtD
Tranylcypromine—Loss of consciousness—Etoposide—urinary bladder cancer	0.000564	0.00232	CcSEcCtD
Tranylcypromine—Hypotension—Fluorouracil—urinary bladder cancer	0.000564	0.00231	CcSEcCtD
Tranylcypromine—Ataxia—Epirubicin—urinary bladder cancer	0.000562	0.00231	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Cisplatin—urinary bladder cancer	0.00056	0.0023	CcSEcCtD
Tranylcypromine—Tachycardia—Cisplatin—urinary bladder cancer	0.000558	0.00229	CcSEcCtD
Tranylcypromine—Insomnia—Gemcitabine—urinary bladder cancer	0.000555	0.00228	CcSEcCtD
Tranylcypromine—Hypertension—Etoposide—urinary bladder cancer	0.000554	0.00228	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Cisplatin—urinary bladder cancer	0.000553	0.00227	CcSEcCtD
Tranylcypromine—Paraesthesia—Gemcitabine—urinary bladder cancer	0.000551	0.00226	CcSEcCtD
Tranylcypromine—Insomnia—Fluorouracil—urinary bladder cancer	0.000546	0.00224	CcSEcCtD
Tranylcypromine—Somnolence—Gemcitabine—urinary bladder cancer	0.000545	0.00224	CcSEcCtD
Tranylcypromine—Anorexia—Cisplatin—urinary bladder cancer	0.000545	0.00224	CcSEcCtD
Tranylcypromine—Paraesthesia—Fluorouracil—urinary bladder cancer	0.000542	0.00222	CcSEcCtD
Tranylcypromine—Somnolence—Fluorouracil—urinary bladder cancer	0.000536	0.0022	CcSEcCtD
Tranylcypromine—Hypotension—Cisplatin—urinary bladder cancer	0.000534	0.00219	CcSEcCtD
Tranylcypromine—Decreased appetite—Gemcitabine—urinary bladder cancer	0.000533	0.00219	CcSEcCtD
Tranylcypromine—Confusional state—Etoposide—urinary bladder cancer	0.000528	0.00217	CcSEcCtD
Tranylcypromine—Pain—Gemcitabine—urinary bladder cancer	0.000525	0.00215	CcSEcCtD
Tranylcypromine—Constipation—Gemcitabine—urinary bladder cancer	0.000525	0.00215	CcSEcCtD
Tranylcypromine—Decreased appetite—Fluorouracil—urinary bladder cancer	0.000524	0.00215	CcSEcCtD
Tranylcypromine—Asthenia—Thiotepa—urinary bladder cancer	0.000523	0.00215	CcSEcCtD
Tranylcypromine—Ataxia—Doxorubicin—urinary bladder cancer	0.00052	0.00213	CcSEcCtD
Tranylcypromine—Pain—Fluorouracil—urinary bladder cancer	0.000516	0.00212	CcSEcCtD
Tranylcypromine—Paraesthesia—Cisplatin—urinary bladder cancer	0.000513	0.00211	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Etoposide—urinary bladder cancer	0.000513	0.00211	CcSEcCtD
Tranylcypromine—Tachycardia—Etoposide—urinary bladder cancer	0.000511	0.0021	CcSEcCtD
Tranylcypromine—Erectile dysfunction—Methotrexate—urinary bladder cancer	0.000508	0.00209	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Etoposide—urinary bladder cancer	0.000506	0.00208	CcSEcCtD
Tranylcypromine—Feeling abnormal—Gemcitabine—urinary bladder cancer	0.000506	0.00208	CcSEcCtD
Tranylcypromine—Anorexia—Etoposide—urinary bladder cancer	0.000499	0.00205	CcSEcCtD
Tranylcypromine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000499	0.00205	CcSEcCtD
Tranylcypromine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000497	0.00204	CcSEcCtD
Tranylcypromine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000497	0.00204	CcSEcCtD
Tranylcypromine—Drowsiness—Methotrexate—urinary bladder cancer	0.000492	0.00202	CcSEcCtD
Tranylcypromine—Hypotension—Etoposide—urinary bladder cancer	0.00049	0.00201	CcSEcCtD
Tranylcypromine—Pain—Cisplatin—urinary bladder cancer	0.000489	0.00201	CcSEcCtD
Tranylcypromine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000485	0.00199	CcSEcCtD
Tranylcypromine—Dizziness—Thiotepa—urinary bladder cancer	0.000482	0.00198	CcSEcCtD
Tranylcypromine—Urticaria—Fluorouracil—urinary bladder cancer	0.000479	0.00197	CcSEcCtD
Tranylcypromine—Pollakiuria—Epirubicin—urinary bladder cancer	0.000477	0.00196	CcSEcCtD
Tranylcypromine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000477	0.00196	CcSEcCtD
Tranylcypromine—Sweating—Methotrexate—urinary bladder cancer	0.000472	0.00194	CcSEcCtD
Tranylcypromine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000471	0.00193	CcSEcCtD
Tranylcypromine—Paraesthesia—Etoposide—urinary bladder cancer	0.00047	0.00193	CcSEcCtD
Tranylcypromine—Somnolence—Etoposide—urinary bladder cancer	0.000466	0.00191	CcSEcCtD
Tranylcypromine—Vomiting—Thiotepa—urinary bladder cancer	0.000464	0.0019	CcSEcCtD
Tranylcypromine—Drowsiness—Epirubicin—urinary bladder cancer	0.00046	0.00189	CcSEcCtD
Tranylcypromine—Rash—Thiotepa—urinary bladder cancer	0.00046	0.00189	CcSEcCtD
Tranylcypromine—Dermatitis—Thiotepa—urinary bladder cancer	0.000459	0.00189	CcSEcCtD
Tranylcypromine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000459	0.00189	CcSEcCtD
Tranylcypromine—Headache—Thiotepa—urinary bladder cancer	0.000457	0.00188	CcSEcCtD
Tranylcypromine—Decreased appetite—Etoposide—urinary bladder cancer	0.000455	0.00187	CcSEcCtD
Tranylcypromine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000452	0.00186	CcSEcCtD
Tranylcypromine—Pain—Etoposide—urinary bladder cancer	0.000448	0.00184	CcSEcCtD
Tranylcypromine—Constipation—Etoposide—urinary bladder cancer	0.000448	0.00184	CcSEcCtD
Tranylcypromine—Haemoglobin—Methotrexate—urinary bladder cancer	0.000444	0.00182	CcSEcCtD
Tranylcypromine—Hepatitis—Methotrexate—urinary bladder cancer	0.000442	0.00181	CcSEcCtD
Tranylcypromine—Haemorrhage—Methotrexate—urinary bladder cancer	0.000442	0.00181	CcSEcCtD
Tranylcypromine—Sweating—Epirubicin—urinary bladder cancer	0.000441	0.00181	CcSEcCtD
Tranylcypromine—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000441	0.00181	CcSEcCtD
Tranylcypromine—Asthenia—Gemcitabine—urinary bladder cancer	0.00044	0.00181	CcSEcCtD
Tranylcypromine—Nausea—Thiotepa—urinary bladder cancer	0.000433	0.00178	CcSEcCtD
Tranylcypromine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000432	0.00177	CcSEcCtD
Tranylcypromine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.00043	0.00176	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000428	0.00176	CcSEcCtD
Tranylcypromine—Drowsiness—Doxorubicin—urinary bladder cancer	0.000426	0.00175	CcSEcCtD
Tranylcypromine—Bradycardia—Epirubicin—urinary bladder cancer	0.000421	0.00173	CcSEcCtD
Tranylcypromine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00042	0.00172	CcSEcCtD
Tranylcypromine—Urticaria—Etoposide—urinary bladder cancer	0.000416	0.00171	CcSEcCtD
Tranylcypromine—Haemoglobin—Epirubicin—urinary bladder cancer	0.000415	0.00171	CcSEcCtD
Tranylcypromine—Abdominal pain—Etoposide—urinary bladder cancer	0.000414	0.0017	CcSEcCtD
Tranylcypromine—Body temperature increased—Etoposide—urinary bladder cancer	0.000414	0.0017	CcSEcCtD
Tranylcypromine—Haemorrhage—Epirubicin—urinary bladder cancer	0.000413	0.0017	CcSEcCtD
Tranylcypromine—Hepatitis—Epirubicin—urinary bladder cancer	0.000413	0.0017	CcSEcCtD
Tranylcypromine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000413	0.00169	CcSEcCtD
Tranylcypromine—Tinnitus—Methotrexate—urinary bladder cancer	0.000412	0.00169	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000411	0.00169	CcSEcCtD
Tranylcypromine—Asthenia—Cisplatin—urinary bladder cancer	0.00041	0.00168	CcSEcCtD
Tranylcypromine—Sweating—Doxorubicin—urinary bladder cancer	0.000408	0.00168	CcSEcCtD
Tranylcypromine—Dizziness—Fluorouracil—urinary bladder cancer	0.000399	0.00164	CcSEcCtD
Tranylcypromine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000398	0.00163	CcSEcCtD
Tranylcypromine—Chills—Methotrexate—urinary bladder cancer	0.000396	0.00163	CcSEcCtD
Tranylcypromine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000391	0.00161	CcSEcCtD
Tranylcypromine—Alopecia—Methotrexate—urinary bladder cancer	0.00039	0.0016	CcSEcCtD
Tranylcypromine—Vomiting—Gemcitabine—urinary bladder cancer	0.00039	0.0016	CcSEcCtD
Tranylcypromine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000389	0.0016	CcSEcCtD
Tranylcypromine—Rash—Gemcitabine—urinary bladder cancer	0.000387	0.00159	CcSEcCtD
Tranylcypromine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000386	0.00159	CcSEcCtD
Tranylcypromine—Tinnitus—Epirubicin—urinary bladder cancer	0.000385	0.00158	CcSEcCtD
Tranylcypromine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000384	0.00158	CcSEcCtD
Tranylcypromine—Headache—Gemcitabine—urinary bladder cancer	0.000384	0.00158	CcSEcCtD
Tranylcypromine—Flushing—Epirubicin—urinary bladder cancer	0.000384	0.00157	CcSEcCtD
Tranylcypromine—Vomiting—Fluorouracil—urinary bladder cancer	0.000384	0.00157	CcSEcCtD
Tranylcypromine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000382	0.00157	CcSEcCtD
Tranylcypromine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000382	0.00157	CcSEcCtD
Tranylcypromine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000381	0.00156	CcSEcCtD
Tranylcypromine—Rash—Fluorouracil—urinary bladder cancer	0.00038	0.00156	CcSEcCtD
Tranylcypromine—Dermatitis—Fluorouracil—urinary bladder cancer	0.00038	0.00156	CcSEcCtD
Tranylcypromine—Headache—Fluorouracil—urinary bladder cancer	0.000378	0.00155	CcSEcCtD
Tranylcypromine—Asthenia—Etoposide—urinary bladder cancer	0.000376	0.00154	CcSEcCtD
Tranylcypromine—Chills—Epirubicin—urinary bladder cancer	0.000371	0.00152	CcSEcCtD
Tranylcypromine—Alopecia—Epirubicin—urinary bladder cancer	0.000365	0.0015	CcSEcCtD
Tranylcypromine—Nausea—Gemcitabine—urinary bladder cancer	0.000364	0.0015	CcSEcCtD
Tranylcypromine—Vomiting—Cisplatin—urinary bladder cancer	0.000364	0.00149	CcSEcCtD
Tranylcypromine—Vision blurred—Methotrexate—urinary bladder cancer	0.000362	0.00149	CcSEcCtD
Tranylcypromine—Rash—Cisplatin—urinary bladder cancer	0.000361	0.00148	CcSEcCtD
Tranylcypromine—Dermatitis—Cisplatin—urinary bladder cancer	0.00036	0.00148	CcSEcCtD
Tranylcypromine—Diarrhoea—Etoposide—urinary bladder cancer	0.000358	0.00147	CcSEcCtD
Tranylcypromine—Nausea—Fluorouracil—urinary bladder cancer	0.000358	0.00147	CcSEcCtD
Tranylcypromine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000357	0.00146	CcSEcCtD
Tranylcypromine—Anaemia—Methotrexate—urinary bladder cancer	0.000355	0.00146	CcSEcCtD
Tranylcypromine—Flushing—Doxorubicin—urinary bladder cancer	0.000355	0.00146	CcSEcCtD
Tranylcypromine—Dizziness—Etoposide—urinary bladder cancer	0.000346	0.00142	CcSEcCtD
Tranylcypromine—Muscle spasms—Epirubicin—urinary bladder cancer	0.000346	0.00142	CcSEcCtD
Tranylcypromine—Leukopenia—Methotrexate—urinary bladder cancer	0.000344	0.00141	CcSEcCtD
Tranylcypromine—Chills—Doxorubicin—urinary bladder cancer	0.000343	0.00141	CcSEcCtD
Tranylcypromine—Nausea—Cisplatin—urinary bladder cancer	0.00034	0.00139	CcSEcCtD
Tranylcypromine—Vision blurred—Epirubicin—urinary bladder cancer	0.000339	0.00139	CcSEcCtD
Tranylcypromine—Alopecia—Doxorubicin—urinary bladder cancer	0.000338	0.00139	CcSEcCtD
Tranylcypromine—Vomiting—Etoposide—urinary bladder cancer	0.000333	0.00137	CcSEcCtD
Tranylcypromine—Anaemia—Epirubicin—urinary bladder cancer	0.000333	0.00137	CcSEcCtD
Tranylcypromine—Agitation—Epirubicin—urinary bladder cancer	0.000331	0.00136	CcSEcCtD
Tranylcypromine—Rash—Etoposide—urinary bladder cancer	0.00033	0.00136	CcSEcCtD
Tranylcypromine—Dermatitis—Etoposide—urinary bladder cancer	0.00033	0.00135	CcSEcCtD
Tranylcypromine—Headache—Etoposide—urinary bladder cancer	0.000328	0.00135	CcSEcCtD
Tranylcypromine—Syncope—Epirubicin—urinary bladder cancer	0.000323	0.00132	CcSEcCtD
Tranylcypromine—Leukopenia—Epirubicin—urinary bladder cancer	0.000322	0.00132	CcSEcCtD
Tranylcypromine—Muscle spasms—Doxorubicin—urinary bladder cancer	0.00032	0.00131	CcSEcCtD
Tranylcypromine—Palpitations—Epirubicin—urinary bladder cancer	0.000318	0.00131	CcSEcCtD
Tranylcypromine—Confusional state—Methotrexate—urinary bladder cancer	0.000316	0.0013	CcSEcCtD
Tranylcypromine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000316	0.0013	CcSEcCtD
Tranylcypromine—Vision blurred—Doxorubicin—urinary bladder cancer	0.000314	0.00129	CcSEcCtD
Tranylcypromine—Nausea—Etoposide—urinary bladder cancer	0.000311	0.00128	CcSEcCtD
Tranylcypromine—Hypertension—Epirubicin—urinary bladder cancer	0.000311	0.00128	CcSEcCtD
Tranylcypromine—Anaemia—Doxorubicin—urinary bladder cancer	0.000308	0.00126	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000307	0.00126	CcSEcCtD
Tranylcypromine—Agitation—Doxorubicin—urinary bladder cancer	0.000306	0.00126	CcSEcCtD
Tranylcypromine—Anxiety—Epirubicin—urinary bladder cancer	0.000305	0.00125	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000303	0.00125	CcSEcCtD
Tranylcypromine—Dry mouth—Epirubicin—urinary bladder cancer	0.0003	0.00123	CcSEcCtD
Tranylcypromine—Anorexia—Methotrexate—urinary bladder cancer	0.000299	0.00123	CcSEcCtD
Tranylcypromine—Syncope—Doxorubicin—urinary bladder cancer	0.000299	0.00123	CcSEcCtD
Tranylcypromine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000298	0.00122	CcSEcCtD
Tranylcypromine—Confusional state—Epirubicin—urinary bladder cancer	0.000296	0.00122	CcSEcCtD
Tranylcypromine—Palpitations—Doxorubicin—urinary bladder cancer	0.000294	0.00121	CcSEcCtD
Tranylcypromine—Oedema—Epirubicin—urinary bladder cancer	0.000294	0.00121	CcSEcCtD
Tranylcypromine—Hypotension—Methotrexate—urinary bladder cancer	0.000293	0.0012	CcSEcCtD
Tranylcypromine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.000293	0.0012	CcSEcCtD
Tranylcypromine—Shock—Epirubicin—urinary bladder cancer	0.000289	0.00119	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000288	0.00118	CcSEcCtD
Tranylcypromine—Hypertension—Doxorubicin—urinary bladder cancer	0.000287	0.00118	CcSEcCtD
Tranylcypromine—Tachycardia—Epirubicin—urinary bladder cancer	0.000287	0.00118	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000284	0.00117	CcSEcCtD
Tranylcypromine—Insomnia—Methotrexate—urinary bladder cancer	0.000284	0.00117	CcSEcCtD
Tranylcypromine—Anxiety—Doxorubicin—urinary bladder cancer	0.000282	0.00116	CcSEcCtD
Tranylcypromine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000282	0.00116	CcSEcCtD
Tranylcypromine—Anorexia—Epirubicin—urinary bladder cancer	0.00028	0.00115	CcSEcCtD
Tranylcypromine—Somnolence—Methotrexate—urinary bladder cancer	0.000279	0.00115	CcSEcCtD
Tranylcypromine—Dry mouth—Doxorubicin—urinary bladder cancer	0.000277	0.00114	CcSEcCtD
Tranylcypromine—Hypotension—Epirubicin—urinary bladder cancer	0.000274	0.00113	CcSEcCtD
Tranylcypromine—Confusional state—Doxorubicin—urinary bladder cancer	0.000274	0.00112	CcSEcCtD
Tranylcypromine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000273	0.00112	CcSEcCtD
Tranylcypromine—Oedema—Doxorubicin—urinary bladder cancer	0.000272	0.00112	CcSEcCtD
Tranylcypromine—Pain—Methotrexate—urinary bladder cancer	0.000268	0.0011	CcSEcCtD
Tranylcypromine—Shock—Doxorubicin—urinary bladder cancer	0.000267	0.0011	CcSEcCtD
Tranylcypromine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000266	0.00109	CcSEcCtD
Tranylcypromine—Insomnia—Epirubicin—urinary bladder cancer	0.000266	0.00109	CcSEcCtD
Tranylcypromine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000265	0.00109	CcSEcCtD
Tranylcypromine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000264	0.00108	CcSEcCtD
Tranylcypromine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000263	0.00108	CcSEcCtD
Tranylcypromine—Somnolence—Epirubicin—urinary bladder cancer	0.000261	0.00107	CcSEcCtD
Tranylcypromine—Anorexia—Doxorubicin—urinary bladder cancer	0.000259	0.00106	CcSEcCtD
Tranylcypromine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000259	0.00106	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000257	0.00105	CcSEcCtD
Tranylcypromine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000255	0.00105	CcSEcCtD
Tranylcypromine—Hypotension—Doxorubicin—urinary bladder cancer	0.000254	0.00104	CcSEcCtD
Tranylcypromine—Pain—Epirubicin—urinary bladder cancer	0.000251	0.00103	CcSEcCtD
Tranylcypromine—Constipation—Epirubicin—urinary bladder cancer	0.000251	0.00103	CcSEcCtD
Tranylcypromine—Urticaria—Methotrexate—urinary bladder cancer	0.000249	0.00102	CcSEcCtD
Tranylcypromine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000248	0.00102	CcSEcCtD
Tranylcypromine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000248	0.00102	CcSEcCtD
Tranylcypromine—Insomnia—Doxorubicin—urinary bladder cancer	0.000246	0.00101	CcSEcCtD
Tranylcypromine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000244	0.001	CcSEcCtD
Tranylcypromine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000242	0.000993	CcSEcCtD
Tranylcypromine—Somnolence—Doxorubicin—urinary bladder cancer	0.000242	0.000992	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.00024	0.000986	CcSEcCtD
Tranylcypromine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000236	0.00097	CcSEcCtD
Tranylcypromine—Urticaria—Epirubicin—urinary bladder cancer	0.000233	0.000958	CcSEcCtD
Tranylcypromine—Pain—Doxorubicin—urinary bladder cancer	0.000232	0.000954	CcSEcCtD
Tranylcypromine—Constipation—Doxorubicin—urinary bladder cancer	0.000232	0.000954	CcSEcCtD
Tranylcypromine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000232	0.000953	CcSEcCtD
Tranylcypromine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000232	0.000953	CcSEcCtD
Tranylcypromine—Asthenia—Methotrexate—urinary bladder cancer	0.000225	0.000924	CcSEcCtD
Tranylcypromine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000224	0.000919	CcSEcCtD
Tranylcypromine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000222	0.000912	CcSEcCtD
Tranylcypromine—Urticaria—Doxorubicin—urinary bladder cancer	0.000216	0.000886	CcSEcCtD
Tranylcypromine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000215	0.000882	CcSEcCtD
Tranylcypromine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000215	0.000882	CcSEcCtD
Tranylcypromine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000215	0.000881	CcSEcCtD
Tranylcypromine—Asthenia—Epirubicin—urinary bladder cancer	0.000211	0.000865	CcSEcCtD
Tranylcypromine—Dizziness—Methotrexate—urinary bladder cancer	0.000208	0.000852	CcSEcCtD
Tranylcypromine—Diarrhoea—Epirubicin—urinary bladder cancer	0.000201	0.000825	CcSEcCtD
Tranylcypromine—Vomiting—Methotrexate—urinary bladder cancer	0.0002	0.000819	CcSEcCtD
Tranylcypromine—Rash—Methotrexate—urinary bladder cancer	0.000198	0.000812	CcSEcCtD
Tranylcypromine—Dermatitis—Methotrexate—urinary bladder cancer	0.000198	0.000812	CcSEcCtD
Tranylcypromine—Headache—Methotrexate—urinary bladder cancer	0.000197	0.000807	CcSEcCtD
Tranylcypromine—Asthenia—Doxorubicin—urinary bladder cancer	0.000195	0.0008	CcSEcCtD
Tranylcypromine—Dizziness—Epirubicin—urinary bladder cancer	0.000194	0.000797	CcSEcCtD
Tranylcypromine—Vomiting—Epirubicin—urinary bladder cancer	0.000187	0.000767	CcSEcCtD
Tranylcypromine—Nausea—Methotrexate—urinary bladder cancer	0.000186	0.000765	CcSEcCtD
Tranylcypromine—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000186	0.000763	CcSEcCtD
Tranylcypromine—Rash—Epirubicin—urinary bladder cancer	0.000185	0.00076	CcSEcCtD
Tranylcypromine—Dermatitis—Epirubicin—urinary bladder cancer	0.000185	0.000759	CcSEcCtD
Tranylcypromine—Headache—Epirubicin—urinary bladder cancer	0.000184	0.000755	CcSEcCtD
Tranylcypromine—Dizziness—Doxorubicin—urinary bladder cancer	0.00018	0.000738	CcSEcCtD
Tranylcypromine—Nausea—Epirubicin—urinary bladder cancer	0.000174	0.000716	CcSEcCtD
Tranylcypromine—Vomiting—Doxorubicin—urinary bladder cancer	0.000173	0.000709	CcSEcCtD
Tranylcypromine—Rash—Doxorubicin—urinary bladder cancer	0.000171	0.000703	CcSEcCtD
Tranylcypromine—Dermatitis—Doxorubicin—urinary bladder cancer	0.000171	0.000703	CcSEcCtD
Tranylcypromine—Headache—Doxorubicin—urinary bladder cancer	0.00017	0.000699	CcSEcCtD
Tranylcypromine—Nausea—Doxorubicin—urinary bladder cancer	0.000161	0.000663	CcSEcCtD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—urinary bladder cancer	0.000113	0.000601	CbGpPWpGaD
Tranylcypromine—MAOA—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	0.00011	0.000585	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTZ1—urinary bladder cancer	0.000109	0.000581	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CYP4B1—urinary bladder cancer	0.000108	0.000574	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—urinary bladder cancer	0.000107	0.000573	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—urinary bladder cancer	0.000107	0.000573	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—GSTP1—urinary bladder cancer	0.000107	0.00057	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—urinary bladder cancer	0.000107	0.000568	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GSTP1—urinary bladder cancer	0.000105	0.000562	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTO2—urinary bladder cancer	0.000103	0.000551	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NAT1—urinary bladder cancer	0.000103	0.000551	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—TYMP—urinary bladder cancer	0.000102	0.000544	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—SLC19A1—urinary bladder cancer	0.000102	0.000542	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PRSS3—urinary bladder cancer	9.9e-05	0.000528	CbGpPWpGaD
Tranylcypromine—CYP1A2—Biological oxidations—GSTM1—urinary bladder cancer	9.82e-05	0.000524	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metapathway biotransformation—GSTM1—urinary bladder cancer	9.69e-05	0.000517	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—NQO1—urinary bladder cancer	9.47e-05	0.000505	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—UGT2B7—urinary bladder cancer	9.44e-05	0.000504	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NAT2—urinary bladder cancer	9.22e-05	0.000492	CbGpPWpGaD
Tranylcypromine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—urinary bladder cancer	9.05e-05	0.000483	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CYP4B1—urinary bladder cancer	8.5e-05	0.000454	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTZ1—urinary bladder cancer	8.4e-05	0.000448	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	8.25e-05	0.00044	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	8.14e-05	0.000434	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—SLC19A1—urinary bladder cancer	8.03e-05	0.000428	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTO2—urinary bladder cancer	7.97e-05	0.000425	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NAT1—urinary bladder cancer	7.97e-05	0.000425	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—RRM2—urinary bladder cancer	7.96e-05	0.000425	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—TYMP—urinary bladder cancer	7.92e-05	0.000422	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSTP1—urinary bladder cancer	7.9e-05	0.000421	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.84e-05	0.000418	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PRSS3—urinary bladder cancer	7.83e-05	0.000417	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	7.73e-05	0.000412	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTZ1—urinary bladder cancer	7.66e-05	0.000409	CbGpPWpGaD
Tranylcypromine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	7.58e-05	0.000404	CbGpPWpGaD
Tranylcypromine—MAOA—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	7.57e-05	0.000404	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.48e-05	0.000399	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ENO2—urinary bladder cancer	7.37e-05	0.000393	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—HPGDS—urinary bladder cancer	7.37e-05	0.000393	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—TYMS—urinary bladder cancer	7.34e-05	0.000392	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	7.33e-05	0.000391	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	7.33e-05	0.000391	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—UGT2B7—urinary bladder cancer	7.29e-05	0.000389	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTO2—urinary bladder cancer	7.26e-05	0.000387	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NAT1—urinary bladder cancer	7.26e-05	0.000387	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—NCOR1—urinary bladder cancer	7.26e-05	0.000387	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GSTM1—urinary bladder cancer	7.26e-05	0.000387	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NAT2—urinary bladder cancer	7.16e-05	0.000382	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTT1—urinary bladder cancer	7.15e-05	0.000381	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	7.14e-05	0.000381	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—GPX1—urinary bladder cancer	6.95e-05	0.000371	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—ERCC2—urinary bladder cancer	6.82e-05	0.000364	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	6.7e-05	0.000357	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—UGT2B7—urinary bladder cancer	6.64e-05	0.000354	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CYP4B1—urinary bladder cancer	6.56e-05	0.00035	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTZ1—urinary bladder cancer	6.55e-05	0.000349	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—MTHFR—urinary bladder cancer	6.41e-05	0.000342	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—TYMP—urinary bladder cancer	6.26e-05	0.000334	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTO2—urinary bladder cancer	6.21e-05	0.000331	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NAT1—urinary bladder cancer	6.21e-05	0.000331	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—SLC19A1—urinary bladder cancer	6.2e-05	0.00033	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—RRM2—urinary bladder cancer	6.18e-05	0.00033	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	6.11e-05	0.000326	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PRSS3—urinary bladder cancer	6.04e-05	0.000322	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	6.03e-05	0.000322	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CYP4B1—urinary bladder cancer	5.98e-05	0.000319	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NQO1—urinary bladder cancer	5.94e-05	0.000317	CbGpPWpGaD
Tranylcypromine—MAOA—Neuronal System—HRAS—urinary bladder cancer	5.8e-05	0.00031	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—HPGDS—urinary bladder cancer	5.72e-05	0.000305	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ENO2—urinary bladder cancer	5.72e-05	0.000305	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	5.7e-05	0.000304	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—UGT2B7—urinary bladder cancer	5.68e-05	0.000303	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NAT2—urinary bladder cancer	5.66e-05	0.000302	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—SLC19A1—urinary bladder cancer	5.65e-05	0.000301	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	5.55e-05	0.000296	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTT1—urinary bladder cancer	5.55e-05	0.000296	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PRSS3—urinary bladder cancer	5.51e-05	0.000294	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PPARG—urinary bladder cancer	5.2e-05	0.000277	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CYP4B1—urinary bladder cancer	5.11e-05	0.000273	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	5.05e-05	0.00027	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—CREBBP—urinary bladder cancer	5e-05	0.000267	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTP1—urinary bladder cancer	4.96e-05	0.000264	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—RRM2—urinary bladder cancer	4.88e-05	0.000261	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.84e-05	0.000258	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—SLC19A1—urinary bladder cancer	4.83e-05	0.000257	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TYMP—urinary bladder cancer	4.83e-05	0.000257	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	4.79e-05	0.000256	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	4.79e-05	0.000256	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PRSS3—urinary bladder cancer	4.7e-05	0.000251	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.64e-05	0.000247	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NQO1—urinary bladder cancer	4.61e-05	0.000246	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—TYMS—urinary bladder cancer	4.61e-05	0.000246	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—NCOR1—urinary bladder cancer	4.55e-05	0.000243	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GSTM1—urinary bladder cancer	4.55e-05	0.000243	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ENO2—urinary bladder cancer	4.52e-05	0.000241	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—HPGDS—urinary bladder cancer	4.52e-05	0.000241	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	4.44e-05	0.000237	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	4.41e-05	0.000235	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TYMP—urinary bladder cancer	4.4e-05	0.000235	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTT1—urinary bladder cancer	4.39e-05	0.000234	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	4.38e-05	0.000234	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NAT2—urinary bladder cancer	4.37e-05	0.000233	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—GPX1—urinary bladder cancer	4.36e-05	0.000233	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—ERCC2—urinary bladder cancer	4.28e-05	0.000228	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	4.23e-05	0.000225	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTGS2—urinary bladder cancer	4.09e-05	0.000218	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—MTHFR—urinary bladder cancer	4.03e-05	0.000215	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	4.01e-05	0.000214	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NAT2—urinary bladder cancer	3.98e-05	0.000212	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	3.95e-05	0.00021	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTP1—urinary bladder cancer	3.85e-05	0.000205	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	3.77e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	3.77e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	3.76e-05	0.000201	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	3.73e-05	0.000199	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	3.65e-05	0.000194	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	3.63e-05	0.000194	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	3.61e-05	0.000193	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—TYMS—urinary bladder cancer	3.58e-05	0.000191	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—PTEN—urinary bladder cancer	3.57e-05	0.00019	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GSTM1—urinary bladder cancer	3.54e-05	0.000189	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—NCOR1—urinary bladder cancer	3.54e-05	0.000189	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	3.49e-05	0.000186	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	3.49e-05	0.000186	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.47e-05	0.000185	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	3.47e-05	0.000185	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	3.44e-05	0.000183	CbGpPWpGaD
Tranylcypromine—MAOB—Metabolism—EP300—urinary bladder cancer	3.4e-05	0.000182	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	3.4e-05	0.000181	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—GPX1—urinary bladder cancer	3.39e-05	0.000181	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	3.38e-05	0.000181	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.33e-05	0.000178	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—ERCC2—urinary bladder cancer	3.32e-05	0.000177	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PPARG—urinary bladder cancer	3.26e-05	0.000174	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	3.21e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	3.21e-05	0.000171	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	3.18e-05	0.00017	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	3.18e-05	0.00017	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	3.16e-05	0.000169	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—CREBBP—urinary bladder cancer	3.14e-05	0.000167	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—MTHFR—urinary bladder cancer	3.12e-05	0.000167	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	3.11e-05	0.000166	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	3.09e-05	0.000165	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	3.04e-05	0.000162	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	3.04e-05	0.000162	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	2.94e-05	0.000157	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	2.9e-05	0.000155	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	2.83e-05	0.000151	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	2.81e-05	0.00015	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	2.79e-05	0.000149	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	2.79e-05	0.000149	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.73e-05	0.000146	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	2.72e-05	0.000145	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	2.72e-05	0.000145	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.7e-05	0.000144	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	2.68e-05	0.000143	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	2.64e-05	0.000141	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	2.63e-05	0.00014	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	2.62e-05	0.00014	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	2.6e-05	0.000139	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	2.59e-05	0.000138	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTGS2—urinary bladder cancer	2.57e-05	0.000137	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	2.56e-05	0.000137	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PPARG—urinary bladder cancer	2.53e-05	0.000135	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.49e-05	0.000133	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	2.47e-05	0.000132	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—CREBBP—urinary bladder cancer	2.43e-05	0.00013	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.38e-05	0.000127	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	2.35e-05	0.000125	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.27e-05	0.000121	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	2.27e-05	0.000121	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—PTEN—urinary bladder cancer	2.24e-05	0.000119	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	2.19e-05	0.000117	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	2.18e-05	0.000116	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	2.17e-05	0.000116	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	2.16e-05	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	2.16e-05	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	2.16e-05	0.000115	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	2.14e-05	0.000114	CbGpPWpGaD
Tranylcypromine—MAOA—Metabolism—EP300—urinary bladder cancer	2.14e-05	0.000114	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	2.13e-05	0.000113	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	2.1e-05	0.000112	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	2.1e-05	0.000112	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	2.07e-05	0.00011	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	2.06e-05	0.00011	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	2.04e-05	0.000109	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	2.03e-05	0.000108	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	2.01e-05	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	2e-05	0.000107	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTGS2—urinary bladder cancer	1.99e-05	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	1.99e-05	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.98e-05	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.98e-05	0.000106	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	1.97e-05	0.000105	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	1.97e-05	0.000105	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	1.92e-05	0.000103	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	1.91e-05	0.000102	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.9e-05	0.000101	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	1.88e-05	0.0001	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.86e-05	9.94e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.85e-05	9.89e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	1.85e-05	9.86e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	1.83e-05	9.75e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.77e-05	9.43e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.75e-05	9.35e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—PTEN—urinary bladder cancer	1.74e-05	9.27e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	1.74e-05	9.27e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	1.7e-05	9.06e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.69e-05	9.02e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	1.68e-05	8.96e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	1.68e-05	8.96e-05	CbGpPWpGaD
Tranylcypromine—CYP2A6—Metabolism—EP300—urinary bladder cancer	1.66e-05	8.84e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	1.61e-05	8.58e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	1.58e-05	8.42e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	1.58e-05	8.4e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	1.55e-05	8.24e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	1.48e-05	7.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	1.48e-05	7.92e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	1.42e-05	7.58e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	1.41e-05	7.53e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	1.41e-05	7.51e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	1.37e-05	7.33e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	1.37e-05	7.28e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	1.35e-05	7.22e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	1.31e-05	7e-05	CbGpPWpGaD
Tranylcypromine—CYP2E1—Metabolism—EP300—urinary bladder cancer	1.31e-05	6.99e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	1.3e-05	6.92e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	1.3e-05	6.92e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	1.24e-05	6.62e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	1.22e-05	6.5e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	1.22e-05	6.48e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	1.2e-05	6.42e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	1.16e-05	6.17e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	1.15e-05	6.11e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	1.12e-05	5.96e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	1.11e-05	5.91e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	1.06e-05	5.65e-05	CbGpPWpGaD
Tranylcypromine—CYP2C19—Metabolism—EP300—urinary bladder cancer	1.01e-05	5.39e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	9.75e-06	5.2e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	9.66e-06	5.16e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	9.47e-06	5.05e-05	CbGpPWpGaD
Tranylcypromine—CYP2D6—Metabolism—EP300—urinary bladder cancer	9.3e-06	4.96e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	9.29e-06	4.96e-05	CbGpPWpGaD
Tranylcypromine—CYP2C9—Metabolism—EP300—urinary bladder cancer	9.22e-06	4.92e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	8.93e-06	4.76e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	8.26e-06	4.41e-05	CbGpPWpGaD
Tranylcypromine—CYP1A2—Metabolism—EP300—urinary bladder cancer	7.88e-06	4.2e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	7.31e-06	3.9e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	6.37e-06	3.4e-05	CbGpPWpGaD
Tranylcypromine—CYP3A4—Metabolism—EP300—urinary bladder cancer	6.08e-06	3.24e-05	CbGpPWpGaD
